INTERPACE BIOSCIENCES, INC. Net Income (Loss) Available to Common Stockholders, Basic
INTERPACE BIOSCIENCES, INC. (IDXGD) reported Net Income (Loss) Available to Common Stockholders, Basic of $24.57 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-03-30
- INTERPACE BIOSCIENCES, INC. net income (loss) available to common stockholders, basic for the quarter ending 2021-12-31 was -$3.73M.
- INTERPACE BIOSCIENCES, INC. net income (loss) available to common stockholders, basic for the quarter ending 2021-09-30 was -$3.56M.
- INTERPACE BIOSCIENCES, INC. net income (loss) available to common stockholders, basic for the quarter ending 2021-06-30 was -$3.45M.
- INTERPACE BIOSCIENCES, INC. net income (loss) available to common stockholders, basic for the quarter ending 2021-03-31 was -$4.21M.
- INTERPACE BIOSCIENCES, INC. net income (loss) available to common stockholders, basic for fiscal 2025 was $24.57M, a 293.96% increase from fiscal 2024.
- INTERPACE BIOSCIENCES, INC. net income (loss) available to common stockholders, basic for fiscal 2024 was $6.24M, a 219.24% increase from fiscal 2023.
- INTERPACE BIOSCIENCES, INC. net income (loss) available to common stockholders, basic for fiscal 2023 was $1.95M.
- INTERPACE BIOSCIENCES, INC. net income (loss) available to common stockholders, basic for fiscal 2021 was -$14.94M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 12 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $24.57M 10-K · filed 2026-03-30 | ||||||
| 2024-12-31 | $6.24M 10-K · filed 2026-03-30 | ||||||
| 2023-12-31 | $1.95M 10-K · filed 2025-03-31 | ||||||
| 2021-12-31 | -$3.73M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$7.29M derived: sum of 2 quarters · filed 2022-03-31 | -$10.74M derived: sum of 3 quarters · filed 2022-03-31 | -$14.94M 10-K · filed 2022-03-31 | |||
| 2021-09-30 | -$3.56M 10-Q · filed 2021-11-10 | -$7.01M derived: sum of 2 quarters · filed 2021-11-10 | -$11.21M 10-Q · filed 2021-11-10 | -$19.36M derived: sum of 4 quarters · filed 2022-03-31 | |||
| 2021-06-30 | -$3.45M 10-Q · filed 2021-08-11 | -$7.65M 10-Q · filed 2021-08-11 | -$15.80M derived: sum of 3 quarters · filed 2022-03-31 | -$22.03M derived: sum of 4 quarters · filed 2022-03-31 | |||
| 2021-03-31 | -$4.21M 10-Q · filed 2021-05-11 | -$12.35M derived: sum of 2 quarters · filed 2022-03-31 | -$18.58M derived: sum of 3 quarters · filed 2022-03-31 | -$24.16M derived: sum of 4 quarters · filed 2022-03-31 | |||
| 2020-12-31 | -$8.14M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$14.38M derived: sum of 2 quarters · filed 2022-03-31 | -$19.96M derived: sum of 3 quarters · filed 2022-03-31 | -$29.48M 10-K · filed 2022-03-31 | |||
| 2020-09-30 | -$6.23M 10-Q · filed 2021-11-10 | -$11.81M derived: sum of 2 quarters · filed 2021-11-10 | -$21.34M 10-Q · filed 2021-11-10 | -$32.36M derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | -$5.58M 10-Q · filed 2021-08-11 | -$15.11M 10-Q · filed 2021-08-11 | -$26.12M derived: sum of 3 quarters · filed 2021-08-11 | -$33.65M derived: sum of 4 quarters · filed 2021-08-11 | |||
| 2020-03-31 | -$9.53M 10-Q · filed 2021-05-11 | -$9.30M 10-Q · filed 2020-06-26 | -$20.54M derived: sum of 2 quarters · filed 2021-05-11 | -$28.07M derived: sum of 3 quarters · filed 2021-05-11 | -$33.37M derived: sum of 4 quarters · filed 2021-05-11 | ||
| 2019-12-31 | -$11.02M derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-01 | -$18.54M derived: sum of 2 quarters · filed 2021-04-01 | -$23.84M derived: sum of 3 quarters · filed 2021-04-01 | -$27.17M 10-K · filed 2021-04-01 | -$27.16M 10-K · filed 2020-04-22 | ||
| 2019-09-30 | -$7.52M 10-Q · filed 2021-01-20 | -$7.44M 10-Q · filed 2019-11-14 | -$12.82M derived: sum of 2 quarters · filed 2021-01-20 | -$16.15M 10-Q · filed 2021-01-20 | -$16.08M 10-Q · filed 2019-11-14 | ||
| 2019-06-30 | -$5.30M 10-Q/A · filed 2021-01-19 | -$8.63M 10-Q/A · filed 2021-01-19 | |||||
| 2019-03-31 | -$3.33M 10-Q/A · filed 2021-01-19 | -$3.42M 10-Q · filed 2020-06-26 | |||||
| 2018-12-31 | -$12.70M 10-K/A · filed 2021-01-19 | -$12.19M 10-K · filed 2020-04-22 |